Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immunogen Inc (IMGN)  
$31.23 0.00 (0.00%) as of 4:30 Thu 2/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 264,900,000
Market Cap: 8.27(B)
Last Volume: 49,305,461 Avg Vol: 7,165,494
52 Week Range: $12.46 - $31.23
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  606
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 233,563 4,785,085 4,785,085
Total Sell Value $0 $6,909,682 $86,338,289 $86,338,289
Total People Sold 0 4 5 5
Total Sell Transactions 0 6 26 26
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 453
  Page 18 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Blattler Walter Executive Vice President   •       •      –    2006-03-06 4 S $4.51 $225,480 D/D (50,000) 124,900     -
   Blattler Walter Executive Vice President   •       •      –    2006-03-06 4 OE $2.50 $187,500 D/D 75,000 174,900     -
   Lambert John Senior Vice President   •       –      –    2006-03-03 4 S $4.50 $225,130 D/D (50,000) 31,291     -
   Lambert John Senior Vice President   •       –      –    2006-03-03 4 OE $2.50 $125,000 D/D 50,000 81,291     -
   Sayare Mitchel officerTitle   •       •      –    2006-01-31 4/A OE $2.50 $150,938 D/D 60,375 386,653     -
   Sayare Mitchel officerTitle   •       •      –    2006-01-31 4 B $2.50 $150,938 D/D 60,375 386,653 2.81     -
   Sayare Mitchel Chief Executive Officer   •       •      –    2005-03-30 4 OE $1.94 $145,350 D/D 75,000 326,278     -
   Blattler Walter Executive Vice President   •       •      –    2005-03-10 4 S $5.22 $93,464 D/D (17,905) 99,900     -
   Blattler Walter Executive Vice President   •       •      –    2005-03-10 4 OE $1.94 $62,198 D/D 32,094 117,805     -
   Blattler Walter Executive Vice President   •       •      –    2005-03-09 4 S $5.23 $93,788 D/D (17,906) 85,711     -
   Blattler Walter Executive Vice President   •       •      –    2005-03-09 4 OE $1.94 $34,702 D/D 17,906 103,617     -
   Lambert John Senior Vice President   •       –      –    2005-03-09 4 S $5.30 $94,357 D/D (17,500) 31,291     -
   Lambert John Senior Vice President   •       –      –    2005-03-09 4 OE $1.94 $33,915 D/D 17,500 48,791     -
   Lambert John Senior Vice President   •       –      –    2005-03-08 4 S $5.40 $40,541 D/D (7,500) 31,291     -
   Lambert John Senior Vice President   •       –      –    2005-03-08 4 OE $1.94 $14,535 D/D 7,500 38,791     -
   Sayare Mitchel Chief Executive Officer   •       •      –    2005-03-02 4 B $5.98 $5,980 D/D 1,000 251,278 2.81     -
   Skaletsky Mark B Director   –       •      –    2004-07-01 4 A $6.07 $4,498 D/D 741 13,759     -
   Blattler Walter Executive Vice President   •       •      –    2004-06-07 4 S $7.13 $52,418 D/D (7,350) 85,711     -
   Blattler Walter Executive Vice President   •       •      –    2004-06-07 4 OE $5.13 $51,250 D/D 10,000 93,061     -
   Lambert John Senior Vice President   •       –      –    2004-06-07 4 S $7.30 $51,100 D/D (7,000) 31,291     -
   Lambert John Senior Vice President   •       –      –    2004-06-07 4 OE $5.13 $35,875 D/D 7,000 38,291     -
   Sayare Mitchel Chief Executive Officer   •       •      –    2004-06-07 4 OE $5.13 $153,750 D/D 30,000 250,278     -
   Shire Pharmaceuticals Group Plc 10% Owner   –       –       •   2004-06-02 4 S $6.71 $27,051,375 D/D (4,030,000) 66,098     -
   Skaletsky Mark B Director   –       •      –    2004-04-01 4 A $6.72 $4,496 D/D 669 13,018     -
   Skaletsky Mark B Director   –       •      –    2004-01-02 4 A $5.05 $4,500 D/D 891 12,349     -
  453 Records found
  Previous  10  11  12  13  14  15  16  17  18  19   
  Page 18 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us